Showing 1 - 6 results of 6 for search 'Umberto Basso', query time: 0.02s
Refine Results
-
1
Robotic approach with neoadjuvant chemotherapy in adult Wilms’ tumor: A feasibility study report and a systematic review of the literature by Simone Sforza, Valeria Emma Palmieri, Maria Rosaria Raspollini, Giandomenico Roviello, Alberto Mantovani, Umberto Basso, Maria Carmen Affinita, Alberto D'Angelo, Lorenzo Antonuzzo, Marco Carini, Andrea Minervini, Lorenzo Masieri
Published 2023-04-01Get full text
Article -
2
Sex differences in toxicity and outcomes in patients with sarcoma treated in the perioperative setting at a comprehensive cancer center by Ilaria Tortorelli, Ilaria Tortorelli, Benedetta Chiusole, Fabio Murtas, Fabio Murtas, Antonella Galiano, Maital Bolshinsky, Selma Ahcene-Djaballah, Chiara De Toni, Salvatore Vizzaccaro, Marco Maruzzo, Umberto Basso, Alberto Banzato, Marina Coppola, Sara Lonardi, Vittorina Zagonel, Antonella Brunello
Published 2025-06-01Get full text
Article -
3
Prostate Cancer Diagnosis and Treatment in Elderly Patients: A Cross-Sectional Survey Exploring Practice Patterns and Preferences of Uro-Oncologists in Northeast Italy by Filippo Carletti, Giuseppe Reitano, Laura Evangelista, Filippo Alongi, Alessandro Antonelli, Umberto Basso, Roberto Bortolus, Matteo Brunelli, Orazio Caffo, Fabrizio Dal Moro, Rocco De Vivo, Mario Gardi, Rossano Girometti, Andrea Guttilla, Fabio Matrone, Matteo Salgarello, Marco Andrea Signor, Fabio Zattoni, Gianluca Giannarini, on behalf of Gruppo Uro-Oncologico del Nord Est (GUONE)
Published 2025-04-01Get full text
Article -
4
Prognostic Value of G8 Geriatric Screening and Meet-URO Scores in Metastatic Renal Cell Carcinoma Patients Receiving First-Line Ipilimumab-Nivolumab Combination Immunotherapy by Ria Nagpal MB, BCh, BAO, Marina Campione PhD, Sara Elena Rebuzzi MD, Lucia Fratino MD, Pasquale Rescigno MD, Sergio Bracarda MD, Davide Bimbatti MD, Ugo De Giorgi MD, Matteo Santoni MD, Fabio Calabrò MD, Mimma Rizzo MD, Alessio Signori PhD, Diana Giannarelli PhD, Giuseppe Fornarini MD, Umberto Basso MD, Giuseppe Luigi Banna MD
Published 2025-02-01Get full text
Article -
5
Pembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON- 1 study by Camillo Porta, Francesco Massari, Tarek Taha, Enrique Grande, Maria T. Bourlon, Ravindran Kanesvaran, Umberto Basso, Javier Molina-Cerrillo, Teresa Alonso-Gordoa, Zin W. Myint, Giuseppe Fornarini, Thomas Buttner, Se Hoon Park, Yüksel Ürün, Ugo De Giorgi, Renate Pichler, Pasquale Rescigno, Tomas Buchler, Hana Studentova, Bohuslav Melichar, Jawaher Ansari, Veronica Mollica, Jakub Kucharz, Mimma Rizzo, Alessandro Rizzo, Ray Manneh Kopp, Sebastiano Buti, Fernando Sabino Marques Monteiro, Andrey Soares, Aristotelis Bamias, Matteo Santoni
Published 2025-05-01Get full text
Article -
6
Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1) by Matteo Santoni, Giandomenico Roviello, Enrique Grande, Ugo De Giorgi, Ondrej Fiala, Emmanuel Seront, Javier Molina-Cerrillo, Renate Pichler, Zin W. Myint, Jakub Kucharz, Ravindran Kanesvaran, Thomas Büttner, Martin Pichler, Umberto Basso, Jindrich Kopecky, Maria T. Bourlon, Linda Cerbone, Tomas Buchler, Alvaro Pinto, Alfonso Gómez de Liaño, Caterina Gianni, Anca Zgura, Pasquale Rescigno, Jawaher Ansari, Orazio Caffo, Zsófia Küronya, Maria Giuseppa Vitale, Dipen Bhuva, Martina Catalano, Nuno Vau, Ray Manneh Kopp, Sebastiano Buti, Aristotelis Bamias, Camillo Porta, Kaisa Sunela, Francesco Massari
Published 2025-05-01Get full text
Article